Anti-interleukin-5 therapy and severe asthma

N Engl J Med. 2009 Jun 11;360(24):2576; author reply 2577. doi: 10.1056/NEJMc090685.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Air Pollution / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Asthma / drug therapy*
  • Asthma / etiology
  • Eosinophilia / drug therapy*
  • Humans
  • Interleukin-5 / antagonists & inhibitors
  • Recurrence

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-5
  • mepolizumab